Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies: Update on Safety in Older Patients

Author： Ornetti Paul   Chevillotte Hélène   Zerrak Amal   Jean Francis Maillefert  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.11, 2006-01, pp. : 855-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Local versus Systemic Anti-Tumour Necrosis Factor-α Effects of Adalimumab in Rheumatoid Arthritis: Pharmacokinetic Modelling Analysis of Interaction between a Soluble Target and a Drug

By Stepensky David  

Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. : 443-455

Adis International

Access to resources Recommend Favorite

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

By Swales Catherine   Bowness Paul  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 219-222

Royal College Of Physicians

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Antagonists in the Management of Rheumatoid Arthritis in the Elderly: A Review of Their Efficacy and Safety

By Radovits Beáta J.   Kievit Wietske   Laan Roland F.J.M.  

Drugs & Aging, Vol. 26, Iss. 8, 2009-08 ,pp. : 647-664

Adis International

Access to resources Recommend Favorite

Guidelines on the use of anti-tumour necrosis factor (TNF) therapies in patients with rheumatoid arthritis (RA) have been updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

By Smith Jeannina A.   Kauffman Carol A.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1403-1415

Adis International

Access to resources Recommend Favorite